In a deal that will end intellectual property claims in five countries, including one before the International Trade Commission, Ascendis has

BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea

Ascendis pagará à BioMarin 20% das vendas líquidas do Yuviwel nos EUA, retroativos à primeira venda comercial, e de 18% das vendas líquidas na União Europeia, na Coreia do Sul e…